Does the Number of Simultaneously Activated Electrodes During Phased RF Multielectrode Ablation of Atrial Fibrillation Influence the Incidence of Silent Cerebral Microembolism?
Overview
Affiliations
Background: Asymptomatic cerebral embolus (ACE) detected by diffusion-weighted magnetic resonance imaging (DW-MRI) following atrial fibrillation (AF) ablation has been reported at varying rates with different ablation techniques.
Objective: To evaluate the incidence of ACE after phased radiofrequency ablation for AF with procedural modifications that potentially reduce the embolic load.
Methods: One hundred twenty consecutive patients with AF underwent MRI before ablation, 24 hours after ablation, and at 4-6 weeks. In all patients, simultaneous activation of pulmonary vein ablation catheter electrode pairs 1 and 5 was forbidden. While in 60 group 1 patients, a maximum of 4 electrode pairs could be activated at a time, and in 60 group 2 patients, ablation was limited to a maximum of 2 pairs. All patients were on uninterrupted phenprocoumon, with an attempted activated clotting time of >300 seconds during ablation.
Results: Both patient groups were comparable. A total of 28 DW-positive lesions were detected in 24 of 120 patients (20%). Seventeen group 1 patients (28.3%) were positive for new asymptomatic DW cerebral lesions compared with 7 group 2 patients (11.7%) (P = .039). During MRI follow-up, 3 patients (2.5%) were diagnosed with a small T2-positive asymptomatic glial scar. Procedure time was longer in group 2 patients than in group 1 patients (159 ± 39 vs 121 ± 15; P < .001).
Conclusions: Limiting the number of simultaneously activated electrode pairs to 2 significantly reduces the rate of ACE in patients treated with a multielectrode duty-cycled phased radiofrequency catheter system for AF. This reduction corresponds with a significant prolongation of the total procedure time.
Preda A, Montalto C, Galasso M, Munafo A, Garofani I, Baroni M Life (Basel). 2023; 13(9).
PMID: 37763223 PMC: 10532856. DOI: 10.3390/life13091819.
Calvert P, Kollias G, Purerfellner H, Narasimhan C, Osorio J, Lip G Europace. 2023; 25(6).
PMID: 37306314 PMC: 10259069. DOI: 10.1093/europace/euad151.
Wieczorek M, Sassani K, Hoeltgen R J Arrhythm. 2020; 36(6):1051-1060.
PMID: 33335624 PMC: 7733583. DOI: 10.1002/joa3.12436.
Lasek-Bal A, Puz P, Wieczorek J, Nowak S, Wnuk-Wojnar A, Warsz-Wianecka A Arch Med Sci. 2020; 16(6):1288-1294.
PMID: 33224327 PMC: 7667434. DOI: 10.5114/aoms.2020.94747.
Wieczorek M, Sassani K, Hoeltgen R Cardiol Res. 2020; 11(3):179-184.
PMID: 32494327 PMC: 7239587. DOI: 10.14740/cr1050.